Status:
RECRUITING
Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Cancer of Pancreas
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
The aim of this work is to evaluate the impact of endoscopic procedures on the circulating tumoral cells level in order to evaluate the potential effects of an endoscopic procedure in the management o...
Detailed Description
The study will include 42 evaluable patients suspected of having pancreatic cancer and for whom an echo-endoscopic biopsy (EUS-FNA) and/or biliary drainage is planned. In these patients, a 6 ml blood...
Eligibility Criteria
Inclusion
- Men and women aged 40-85 years old;
- BMI\< 30 kg/m2;
- Patients suspected of having pancreatic cancer for whom an ultrasound endoscopic biopsy and/or biliary drainage is planned;
- Affiliation to, or beneficiary of, a social security scheme.
Exclusion
- Woman who is pregnant or likely to become pregnant (without effective contraception) or breastfeeding ;
- Person in an emergency situation, person of full age subject to a legal protection measure, or unable to express consent;
- Biliary drainage or attempt at prior biliary drainage outside the center ;
- Preliminary oncological treatment for pancreatic pathology covered by the study;
- Clinical and/or image-visible (CT/MRI) carcinosis ;
- Ascites visible on imaging (CT/MRI) ;
- Impossibility to undergo the medical follow-up of the trial for geographical, social or psychological reasons;
- Contraindications to an endoscopic procedure.
Key Trial Info
Start Date :
November 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04677244
Start Date
November 11 2021
End Date
November 1 2025
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli Calmettes
Marseille, France, 13009